CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia

• मुख्य लेखकों: Carlos Cuesta-Mateos (लेखक), Patricia Fuentes (लेखक), Alexandra Schrader (लेखक), Raquel Juárez-Sánchez (लेखक), Javier Loscertales (लेखक), Tamara Mateu-Albero (लेखक), Lorena Vega-Piris (लेखक), Marina Espartero-Santos (लेखक), Ana Marcos-Jimenez (लेखक), Blanca Andrea Sánchez-López (लेखक), Yaiza Pérez-García (लेखक), Dennis Jungherz (लेखक), Sebastian Oberbeck (लेखक), Linus Wahnschaffe (लेखक), Anna Kreutzman (लेखक), Emma I. Andersson (लेखक), Satu Mustjoki (लेखक), Edgar Faber (लेखक), Ana Urzainqui (लेखक), Manuel Fresno (लेखक), Kostantino Stamatakis (लेखक), Arantzazu Alfranca (लेखक), Fernando Terrón (लेखक), Marco Herling (लेखक), María Luisa Toribio (लेखक), Cecilia Muñoz-Calleja (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: BMC, 2020-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract T-cell prolymphocytic leukemia (T-PLL) is a poor prognostic disease with very limited options of efficient therapies. Most patients are refractory to chemotherapies and despite high response rates after alemtuzumab, virtually all patients relapse. Therefore, there is an unmet medical need f...